Document Detail


A comparison of aztreonam and ceftazidime in the treatment of respiratory infections in adults with cystic fibrosis.
MedLine Citation:
PMID:  1641599     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A randomised double blind 2-week trial of monotherapy with ceftazidime and aztreonam was completed in 22 adults with cystic fibrosis. 26 courses of treatment were initiated and 22 courses were completed. Within groups, both ceftazidime and aztreonam demonstrated a significant improvement in FEV1 at 2 weeks (ceftazidime p less than 0.05; aztreonam p less than 0.01) and a decline in sputum weight at 2 weeks (ceftazidime p less than 0.05; aztreonam p less than 0.05). Between groups, for spirometry and sputum weight the only change was a slower decline in FEV1 in the aztreonam group at 42 days (p less than 0.05).
Authors:
B Salh; D Bilton; M Dodd; J Abbot; K Webb
Related Documents :
3516509 - Phenylpropanolamine oros (acutrim) vs. placebo in combination with caloric restriction ...
19637289 - Aerobic exercise training reduces hepatic and visceral lipids in obese individuals with...
15860689 - Exercise without weight loss is an effective strategy for obesity reduction in obese in...
2031499 - Cuidando el corazon--a weight-reduction intervention for mexican americans.
6465309 - Catecholamine responses to hypocaloric diets and fasting in obese human subjects.
18580399 - Exercise attenuates the weight-loss-induced reduction in muscle mass in frail obese old...
7954889 - Rehabilitation of isolated and combined posterior cruciate ligament injuries.
14657039 - Postexercise protein supplementation improves health and muscle soreness during basic m...
22685479 - Evaluation of functional electrical stimulation to assist cycling in four adolescents w...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Scandinavian journal of infectious diseases     Volume:  24     ISSN:  0036-5548     ISO Abbreviation:  Scand. J. Infect. Dis.     Publication Date:  1992  
Date Detail:
Created Date:  1992-09-01     Completed Date:  1992-09-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0215333     Medline TA:  Scand J Infect Dis     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  215-8     Citation Subset:  IM    
Affiliation:
Adult Regional Cystic Fibrosis Unit, Monsall Hospital, Manchester, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aztreonam / therapeutic use*
Ceftazidime / therapeutic use*
Cystic Fibrosis / complications*
Double-Blind Method
Female
Forced Expiratory Volume
Humans
Male
Pseudomonas aeruginosa / isolation & purification,  ultrastructure
Respiratory Tract Infections / drug therapy*,  etiology
Sputum / microbiology
Chemical
Reg. No./Substance:
78110-38-0/Aztreonam; 78439-06-2/Ceftazidime

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The differential leukocyte count in adults with acute gastroenteritis.
Next Document:  Efficacy and tolerance of roxithromycin in comparison with erythromycin stearate in patients with lo...